Download now: life sciences - whitepaper: building an investable ip portfolio
​

Make your bio(pharma) IP investment ready

​
March 22, 2026

Download PDF

Table of contents
  • Toc Heading
  • Toc Heading
Gareth Probert
Partner, UK and European Patent Attorney, UPC Representative
Rob Barker
Partner, UK and European Patent Attorney, Design Attorney, UPC Representative
Tim Belcher
Partner, UK and European Patent Attorney, UPC Representative

Whether you’re scaling or planning your next strategic step, these sessions will share practical insights to help future‑proof your IP and strengthen your investment story.

Episode 1: How to build a resilient IP portfolio in the (bio)pharma sector

How you structure and protect intellectual property can be critical to securing investment in the biopharma sector. In this first episode of EIP’s LinkedIn Live series, our biopharma IP experts examine what investors look for in an investment‑ready biopharma IP portfolio, and how companies can position their patent strategy to support funding, partnerships, and long‑term value creation.

Gareth Probert, Head of Biopharma & Chemistry, and Tim Belcher, Partner in EIP’s Biopharma team, focus on three core pillars that consistently influence investor due diligence and valuation: who owns the IP, what should be protected, and when patent applications should be filed.
‍

Episode 2: Strategic IP moves to consider when preparing for an investment round

In this second episode of EIP’s LinkedIn Live series, Tim Belcher and Rob Barker explore the strategic IP decisions biopharma companies should make ahead of investment rounds. From aligning patent strategy with investor expectations to managing disclosures, due diligence, freedom‑to‑operate, and data rooms, the session outlines practical steps to reduce risk, build credibility, and position IP as a core driver of valuation and deal success.

‍

Episode 3: A forward look at the 2026 (bio)pharma landscape and what it means for your business and IP strategy

In the final episode of EIP’s LinkedIn Live series, Gareth Probert and Robert Barker explore what the year ahead holds for biopharma investment and IP strategy. The discussion highlights renewed optimism and increasing deal activity as the sector emerges from a period of reduced investment. With major pharmaceutical companies facing significant patent cliffs, attention is shifting towards external innovation, particularly later‑stage and proof‑of‑concept assets that can replenish pipelines quickly.

The Latest Thought Leadership pieces in the Content Hub

See all articles

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

​
Interested in a career at EIP?

View Open Roles

Heading
This is some text inside of a div block.
This is some text inside of a div block.
​

Latest Insights

Showing 0 of 100
Filters
Data Detection Technologies Ltd v Doytec Automation Ltd UPC_CFI_554/2024
23 May 2025
Order of 25 September 2024 [1] This Order to Preserve Evidence pursuant to Art. 60 UPCA concerns a machine manufactured by the defendant that was being displayed at a 3-day trade fair.
#
Litigation
​
Quantum Sensors: What are they and why do they matter to healthcare?
19 May 2025
The UN says we are in a year of quantum, celebrating 100 years since the development of quantum mechanics. While quantum computing is often the main talking point, the other areas of quantum tech,...
#
Consulting
​
Exploring IP in a Space Sector Product
09 May 2025
Introduction Innovative space sector businesses generate IP all the time. But it can be difficult to appreciate the range of IP being generated, or the value of that IP.
#
Patenting
​
Charged Up: Are we missing the potential of domestic battery storage for the energy transition?
21 May 2024
It's accepted that batteries will play a more and more important role in managing electricity demand as we transition to a greater proportion of renewables, but have we been thinking about them in...
#
Patenting
​
AI and Big Data in Agritech
28 March 2024
First published by Process Engineering - February 2024 The world's population stands above 8 billion in 2024 and is still growing. That growth may be slowing down but nonetheless there may be another...
#
Patenting
​
Trade Secrets vs. Patents in the UK Space Sector
11 September 2023
In this article we take a look at how trade secrets and patents compare as means of protecting inventions by UK space sector businesses. Background Properly protecting intellectual property is a key...
#
Patenting
​
A Year in Patents - Part 3/4: The Procedures of International Patent Prosecution
05 September 2023
Dr Girish Nivarti joined EIP's London office in October 2022. In this four-part series, he chronicles his first year as a trainee patent attorney.
#
Patenting
​
The UK National Semiconductor Strategy: a first glance
23 May 2023
The UK Government has released its National Semiconductor Strategy. The Strategy sets out the UK Government's vision for the semiconductor industry in the UK, and details funding and other...
#
Patenting
​
The Deep Non-Thinker
27 April 2023
Lock up your authors! ChatGPT is here! And it's coming for your IP! The internet is awash with content written about, or written by, the new chat-bot in town, ChatGPT.
#
Consulting
​
Geographic Scope of the UPC and Unitary Patent
22 February 2023
The grant of a European Patent allows patent rights to be obtained in respect of over 35 states by means of the respective validation procedures for those states.
#
Litigation
​
A Year in Patents - Part 1/4: Swapping Simulations for the Patent Profession
14 February 2023
Dr Girish Nivarti joined EIP's London office in October 2022. In this four-part series, he chronicles his first year as a trainee patent attorney.
#
Patenting
​
Opt-out decision
02 December 2022
Owners of European patent rights (both pending and granted patents) need to decide, in respect of each right individually, whether to opt out of the Unified Patent Court ("UPC") system.
#
Litigation
​
Information from the UPC Registry
01 December 2022
The Registry of the Unified Patent Court maintains a number of Registers which are publicly accessible via their website at www.unified-patent-court.org.
#
Patenting
​
Unitary Patent as an object of property
09 November 2022
A registered intellectual property right such as a patent is normally considered a property right of the country in which it has effect. Rules relating to the patent as an object of property, for...
#
Patenting
​
What are the options if you want to avoid the UPC?
03 November 2022
During the transitional period, it is possible to opt classical (i.e. non-unitary) European patents and applications out of the competence of the UPC (provided that no action has commenced at the UPC...
#
Patenting
​